Previous 10 | Next 10 |
IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources New executive appointment made commensurate with IceCure's growth related to the increased adoption of its flagship ProSense® Cryoablation System and development of next-generation of...
IceCure Medical (NASDAQ:ICCM): 9M GAAP EPS of $0.249. Revenue of $2.75M (+10.4% Y/Y) Press Release For further details see: IceCure Medical reports 9M results
IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments PR Newswire CAESAREA, Israel , Nov. 23, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), dev...
IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™ IceCure Medical Announces New Independent Data Published in ...
Diginex (NASDAQ:EQOS) +70% on its crypto exchange, EQONEX listing Polkadot token on its platform Bakkt Holdings (NYSE:BKKT) +67% after agreements with Fiserv, Mastercard Wallbox (NYSE:WBX) +56% Uber and Wallbox team up on the road to zero emissions Code Chain New Continent (NAS...
Gainers: IceCure Medical (NASDAQ:ICCM) +15%, Kiromic BioPharma KRBP +12%, Eargo (NASDAQ:EAR) +12%, Context Therapeutics (NASDAQ:CNTX) +11%, Xeris Biopharma XERS +11%. Losers: ERYTECH Pharma ERYP -39%, Eyenovia EYEN -37%, Es...
Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...
LumiraDx (NASDAQ:LMDX) +37% after approval for COVID-19 antigen test in India Troika Media (NASDAQ:TRKA) +32%. Puhui Wealth Investment Management (NASDAQ:PHCF) +16%. Valneva (NASDAQ:VALN) +16%. Xiaobai Maimai (NASDAQ:HX) +11%. Cyclerion Therapeutics (NASDAQ:CYCN) +11%. F-star ...
IceCure Medical Enters into an Exclusive Agreement in Poland for Distribution of the ProSense™ Cryoablation System PR Newswire CAESAREA, Israel , Oct. 20, 2021 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), d...
IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation IceCure submitted an amendment to the registration certificate granted for the IceSense3 System by China's NMPA, which will allow IceCure to ...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...